Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.10
Bid: 47.10
Ask: 47.20
Change: -0.85 (-1.77%)
Spread: 0.10 (0.212%)
Open: 48.20
High: 48.20
Low: 46.85
Prev. Close: 47.95
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio co Oxbotica completes £36m funding round

6 Jan 2021 07:00

RNS Number : 6850K
IP Group PLC
06 January 2021
 

FOR RELEASE ON

06 January 2021

 

 

IP Group plc - Portfolio company Oxbotica completes £36m funding round

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that portfolio company Oxbotica Ltd, a global leader in autonomous vehicle software, has announced that it has raised £36.0 million of new capital in a Series B round from both new and existing investors.

 

Following completion of the transaction, IP Group will hold a direct undiluted beneficial stake of 15.0% in Oxbotica. IP Group committed £4.0 million to the round which was led by bp ventures with funding from other investors including BGF, Halma, HostPlus,Tencent, Venture Science and funds advised by Doxa Partners. The funding will be used to accelerate Oxbotica's commercial deployment of its autonomy software platform across multiple industries and key markets.

 

Oxbotica's product is a software platform providing Universal Autonomy. It is fast to deploy, low energy, hassle free, hardware agnostic autonomy and applicable to a vast array of vehicle types both on and off road. The advanced technology supports Oxbotica's unique horizontal B2B model providing operators, integrators and manufacturers the autonomy functionality and flexibility they need be that a full stack or on a component-by-component basis.

 

Jamie Vollbracht, Partner, Cleantech at IP Group plc, said: "Oxbotica provides autonomy where it makes sense today: delivering safety, cost and environmental benefits. Two years after IP Group's first investment, we are delighted to be able to welcome multiple value-adding investors to the share register. This substantial funding round will enable Oxbotica to move to the next stage, delivering those benefits in multiple applications across the globe."

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Greg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

Group holdings in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

 

For more information, please visit our website at www.ipgroupplc.com.

 

About Oxbotica

 

Oxbotica is a global leader in autonomous vehicle software. Oxbotica was founded in 2014 as an Oxford University spin-out with a simple mission to develop autonomy software that will transform all

industries where people and goods move. Oxbotica's autonomy software works with any vehicle, any

time, and in any place. This is Universal Autonomy. Oxbotica's autonomous vehicle software is deployed across multiple industries, bringing the benefits of autonomy to enterprises globally. Oxbotica is building an ecosystem that supports the adoption of autonomous vehicles, leveraging key partnerships to accelerate the deployment of Universal Autonomy.

 

ENDS

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADKPBQFBKDDDK
Date   Source Headline
21st Sep 20225:29 pmRNSHolding(s) in Company
20th Sep 20226:10 pmRNSDirector/PDMR Shareholding
15th Sep 20224:41 pmRNSInvestor presentation
14th Sep 20224:33 pmRNSFurther re Scrip Dividend
13th Sep 20226:00 pmRNSFurther re Interim Scrip Dividend
13th Sep 20227:01 amEQSIP Group Trust (IPO): Initiation — International investor in impactful innovation
7th Sep 20224:33 pmRNSDirector/PDMR Shareholding, SAYE scheme
31st Aug 20228:51 amRNSIstesso starts Phase 2b trial of MBS2320
30th Aug 202212:59 pmRNSCash acquisition of portfolio company Diurnal
18th Aug 20229:25 amRNSScrip Dividend Reference Price
11th Aug 202210:50 amRNSHolding(s) in Company
3rd Aug 20227:00 amRNSHalf-yearly results
2nd Aug 20227:00 amRNSPortfolio company Hysata completes funding round
13th Jul 20229:30 amRNSNotice of Results
30th Jun 20225:46 pmRNSRSP awards and Scrip Elections
29th Jun 20229:16 amRNSFurther re Scrip Dividend
22nd Jun 20227:00 amRNSLaunches ‘Kiko Ventures’ cleantech platform
16th Jun 202211:27 amRNSDirector/PDMR Shareholding
14th Jun 20227:00 amRNSAGM Statement
8th Jun 20227:30 amRNSTR-1
6th Jun 20228:14 amRNSScrip Dividend Reference Price
1st Jun 20223:23 pmRNSInvestor presentation; AGM arrangements
13th May 202212:43 pmRNSDirector Declaration
9th May 20225:21 pmRNSNotice of AGM, Annual Report
29th Apr 20223:46 pmRNSTotal Voting Rights
27th Apr 20226:16 pmRNSDirector/PDMR Shareholding
25th Apr 20226:09 pmRNSDBSP awards; Director/PDMR shareholding
5th Apr 20227:00 amRNSPortfolio company First Light achieves fusion
16th Mar 20227:00 amRNSAnnual Results
7th Mar 20228:00 amRNSPortfolio co Microbiotica completes £50m raise
2nd Mar 20229:19 amRNSNotice of Results
14th Feb 20227:00 amRNSPortfolio company Bramble raises £35m
14th Feb 20227:00 amRNSPortfolio co First Light completes $45m fund raise
28th Jan 20225:02 pmRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
27th Jan 20227:00 amRNSTransaction in Own Shares
25th Jan 20225:45 pmRNSHolding(s) in Company
25th Jan 20225:39 pmRNSTransaction in Own Shares
24th Jan 20225:58 pmRNSTransaction in Own Shares
24th Jan 20227:00 amRNSTransaction in Own Shares
20th Jan 20225:52 pmRNSTransaction in Own Shares
19th Jan 20226:12 pmRNSTransaction in Own Shares
18th Jan 20225:52 pmRNSTransaction in Own Shares
18th Jan 20221:00 pmRNSHolding(s) in Company
18th Jan 20227:00 amRNSTransaction in Own Shares
14th Jan 20226:13 pmRNSTransaction in Own Shares
13th Jan 20226:06 pmRNSTransaction in Own Shares
13th Jan 20227:00 amRNSPre-closed-period update
12th Jan 20226:06 pmRNSTransaction in Own Shares
11th Jan 20225:26 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.